Michael Geffner, the Chief Medical Officer of $IMVT, sold 1,160 shares of the company on 07-09-2025 for an estimated $19,998. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.5% of their shares of this class of stock. Following this trade, they now own 224,210 shares of this class of $IMVT stock.
$IMVT Insider Trading Activity
$IMVT insiders have traded $IMVT stock on the open market 20 times in the past 6 months. Of those trades, 1 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $IMVT stock by insiders over the last 6 months:
- SCIENCES LTD. ROIVANT purchased 16,845,010 shares for an estimated $336,900,200
- PETER SALZMANN (Chief Executive Officer) has made 0 purchases and 4 sales selling 45,182 shares for an estimated $697,740.
- ANDREW J. FROMKIN has made 0 purchases and 2 sales selling 8,000 shares for an estimated $156,768.
- MICHAEL GEFFNER (Chief Medical Officer) has made 0 purchases and 3 sales selling 6,166 shares for an estimated $117,418.
- JAY S STOUT (Chief Technology Officer) has made 0 purchases and 3 sales selling 5,639 shares for an estimated $106,438.
- EVA RENEE BARNETT (Chief Financial Officer) has made 0 purchases and 3 sales selling 5,291 shares for an estimated $99,322.
- WILLIAM L. MACIAS (Chief Medical Officer) has made 0 purchases and 4 sales selling 2,383 shares for an estimated $56,782.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$IMVT Hedge Fund Activity
We have seen 122 institutional investors add shares of $IMVT stock to their portfolio, and 68 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 4,143,120 shares (+31.6%) to their portfolio in Q1 2025, for an estimated $70,805,920
- BAKER BROS. ADVISORS LP added 3,750,000 shares (+219.6%) to their portfolio in Q1 2025, for an estimated $64,087,500
- DEEP TRACK CAPITAL, LP added 3,500,000 shares (+58.3%) to their portfolio in Q1 2025, for an estimated $59,815,000
- FRANKLIN RESOURCES INC removed 984,063 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $16,817,636
- WOODLINE PARTNERS LP added 855,143 shares (+133.0%) to their portfolio in Q1 2025, for an estimated $14,614,393
- BOXER CAPITAL MANAGEMENT, LLC removed 825,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $14,099,250
- POINT72 ASSET MANAGEMENT, L.P. added 801,927 shares (+inf%) to their portfolio in Q1 2025, for an estimated $13,704,932
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$IMVT Analyst Ratings
Wall Street analysts have issued reports on $IMVT in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 03/20/2025
- B of A Securities issued a "Buy" rating on 03/20/2025
- HC Wainwright & Co. issued a "Buy" rating on 03/19/2025
To track analyst ratings and price targets for $IMVT, check out Quiver Quantitative's $IMVT forecast page.
$IMVT Price Targets
Multiple analysts have issued price targets for $IMVT recently. We have seen 4 analysts offer price targets for $IMVT in the last 6 months, with a median target of $38.5.
Here are some recent targets:
- Colin Bristow from UBS set a target price of $17.0 on 04/22/2025
- Jason Gerberry from B of A Securities set a target price of $33.0 on 03/20/2025
- Douglas Tsao from HC Wainwright & Co. set a target price of $51.0 on 03/19/2025
- Yatin Suneja from Guggenheim set a target price of $44.0 on 02/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
